Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGNY · against 596 other Healthcare companies listed in US-listed
Ranked #293 of 597 · scores higher than 51% of peers · safety percentile 47
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 40–49, including PGNY · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PGNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.06× | 0.23× | 70% | 33% | |
| BetaLower is better · 556 reported | 1.02 | 0.95 | 46% | 33% | |
| Current ratioHigher is better · 600 reported | 2.14× | 3.91× | 31% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 289 | 35.0B USD | 48 | 52 | |
| 290 | 7.0B USD | 48 | 63 | |
| 291 | 467M USD | 47 | 44 | |
| 292 | 37M USD | 47 | 21 | |
| 293 | 2.2B USD | 47 | 66 | |
| 294 | 1.9B USD | 47 | 44 | |
| 295 | 10.0B USD | 46 | 43 | |
| 296 | 1.7B USD | 46 | 77 | |
| 297 | Unavailable | 45 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score